Home > Insider Trading > Filing (0001628280-20-001351)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753159	Amirali Talasaz	505 Penobscot Drive Redwood City CA 94063	Chairman, President And Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-12-20	2,647	$83.00	71,060	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,199,221	Indirect	Shares held by Talasaz and Eskandari 2017 Family Trust
Common Stock	737,800	Indirect	Shares held by Talasaz Investments, L.P.

Footnotes

These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.83 to $83.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person does not serve as a trustee or exercise any control over the securities held by the Samar Talasaz 2018 Irrevocable Trust or the Sana Talasaz 2018 Irrevocable Trust, and thus, the Reporting Person is not deemed to indirectly hold such securities.
This transaction is being repeated on this amended Form 4 solely to correct the indirect holdings of the Reporting Person.